OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
Apollo Therapeutics is a portfolio biopharmaceutical company based in the UK and USA. They translate breakthroughs in biology and basic medical research into innovative new medicines. With over 20 active therapeutic programs, six of which are in development, they are building a large, diversified portfolio of novel therapeutics with uncorrelated risk. Apollo Therapeutics and the University of Oxford have entered into drug discovery and development collaboration
The seminar will be followed by lunch and and networking.
